These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 8741813

  • 41. [RBC Na(+)-Li+ countertransport and Na(+)-K+ cotransport in patients with essential hypertension].
    Zhang GS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Aug; 21(4):204-6, 252. PubMed ID: 8194429
    [Abstract] [Full Text] [Related]

  • 42. Erythrocyte cation transport systems and membrane lipids in insulin-dependent diabetes.
    Lijnen P, Fenyvesi A, Bex M, Bouillon R, Amery A.
    Am J Hypertens; 1993 Sep; 6(9):763-70. PubMed ID: 8110430
    [Abstract] [Full Text] [Related]

  • 43. Red blood cell sodium-lithium countertransport in patients with essential and renal hypertension.
    Petrov VV, Arabidze CG, Levitsky DO, Eliseev AO, Lijnen PJ.
    Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):153-7. PubMed ID: 8007744
    [Abstract] [Full Text] [Related]

  • 44. Genetic polymorphisms and erythrocyte sodium-lithium countertransport in essential hypertension.
    Tournoy KG, Delanghe JR, Duprez DA, De Buyzere ML, Verbeeck RM, Vergauwe DA, Leroux-Roels GG, Clement DL.
    Clin Chim Acta; 1996 Nov 15; 255(1):39-55. PubMed ID: 8930412
    [Abstract] [Full Text] [Related]

  • 45. Sodium/lithium countertransport, insulin resistance, insulin peptides and microalbuminuria in clinically healthy 58-year-old men.
    Herlitz H, Bokemark L, Alenhag EL, Wikstrand J, Fagerberg B.
    Clin Sci (Lond); 2001 Apr 15; 100(4):443-9. PubMed ID: 11256986
    [Abstract] [Full Text] [Related]

  • 46. Heritability of erythrocyte Na+-Li+ countertransport in relation to essential hypertension.
    Kagamimori S, Takata M, Naruse Y, Watanabe M, Miyamoto N, Okada A.
    Clin Exp Hypertens A; 1984 Apr 15; 6(5):951-60. PubMed ID: 6329557
    [Abstract] [Full Text] [Related]

  • 47. Mixture analysis of erythrocyte lithium-sodium countertransport and blood pressure.
    Weder AB, Schork NJ.
    Hypertension; 1989 Feb 15; 13(2):145-50. PubMed ID: 2914736
    [Abstract] [Full Text] [Related]

  • 48. Changes in sodium-lithium countertransport correlate with changes in triglyceride levels and body mass index over 2 1/2 years of follow-up in Utah.
    Hunt SC, Williams RR, Ash KO.
    Cardiovasc Drugs Ther; 1990 Mar 15; 4 Suppl 2():357-62. PubMed ID: 2271398
    [Abstract] [Full Text] [Related]

  • 49. Relevance of erythrocyte Na+/Li+ countertransport measurement in essential hypertension, hyperlipidaemia and diabetic nephropathy: a critical review.
    Van Norren K, Thien T, Berden JH, Elving LD, De Pont JJ.
    Eur J Clin Invest; 1998 May 15; 28(5):339-52. PubMed ID: 9650006
    [Abstract] [Full Text] [Related]

  • 50. Sodium-lithium countertransport kinetics in IgA nephropathy: relation to plasma lipids and renal impairment.
    Ho KK, Thomas TH, Rutherford PA, Wilkinson R.
    Nephron; 1995 May 15; 69(4):391-6. PubMed ID: 7777102
    [Abstract] [Full Text] [Related]

  • 51. Erythrocyte sodium-lithium countertransport and proliferative diabetic retinopathy.
    Lopes de Faria JM, Silveira LA, Morgano M, Pavin EJ, Lopes de Faria JB.
    Invest Ophthalmol Vis Sci; 2000 May 15; 41(6):1482-5. PubMed ID: 10798666
    [Abstract] [Full Text] [Related]

  • 52. Serum lipoprotein(a) is increased in hypertensive NIDDM patients.
    Hancu N, Netea MG, Iancu S.
    Diabetes Care; 1995 Jun 15; 18(6):879-80. PubMed ID: 7555518
    [No Abstract] [Full Text] [Related]

  • 53. Red blood cell sodium-lithium countertransport and risk of future hypertension: the Olivetti Prospective Heart Study.
    Strazzullo P, Siani A, Cappuccio FP, Trevisan M, Ragone E, Russo L, Iacone R, Farinaro E.
    Hypertension; 1998 Jun 15; 31(6):1284-9. PubMed ID: 9622143
    [Abstract] [Full Text] [Related]

  • 54. Assessing the role of APNH, a gene encoding for a human amiloride-sensitive Na+/H+ antiporter, on the interindividual variation in red cell Na+/Li+ countertransport.
    Dudley CR, Giuffra LA, Raine AE, Reeders ST.
    J Am Soc Nephrol; 1991 Oct 15; 2(4):937-43. PubMed ID: 1661190
    [Abstract] [Full Text] [Related]

  • 55. Sodium-lithium countertransport and blood pressure in healthy blood donors.
    Turner ST, Johnson M, Boerwinkle E, Richelson E, Taswell HF, Sing CF.
    Hypertension; 1985 Oct 15; 7(6 Pt 1):955-62. PubMed ID: 4077225
    [Abstract] [Full Text] [Related]

  • 56. Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy.
    Jensen JS, Mathiesen ER, Nørgaard K, Hommel E, Borch-Johnsen K, Funder J, Brahm J, Parving HH, Deckert T.
    Diabetologia; 1990 Oct 15; 33(10):619-24. PubMed ID: 2257999
    [Abstract] [Full Text] [Related]

  • 57. Elevated sodium-lithium countertransport: a familial marker of hyperlipidaemia and hypertension?
    Carr SJ, Thomas TH, Laker MF, Wilkinson R.
    J Hypertens; 1990 Feb 15; 8(2):139-46. PubMed ID: 2162876
    [Abstract] [Full Text] [Related]

  • 58. Increased erythrocyte lithium--sodium countertransport in essential hypertension: its relationship to family history of hypertension.
    Canali M, Borghi L, Sani E, Curti A, Montanari A, Novarini A, Borghetti A.
    Clin Sci (Lond); 1981 Dec 15; 61 Suppl 7():13s-15s. PubMed ID: 7318313
    [Abstract] [Full Text] [Related]

  • 59. Red cell Na+/Li+ countertransport and Na+/H+ exchanger isoforms in human proximal tubules.
    Ng LL, Quinn PA, Baker F, Carr SJ.
    Kidney Int; 2000 Jul 15; 58(1):229-35. PubMed ID: 10886567
    [Abstract] [Full Text] [Related]

  • 60. Nisoldipine improves the impaired erythrocyte deformability correlating with elevated intracellular free calcium-ion concentration and poor glycaemic control in NIDDM.
    Fujita J, Tsuda K, Takeda T, Yu L, Fujimoto S, Kajikawa M, Nishimura M, Mizuno N, Hamamoto Y, Mukai E, Adachi T, Seino Y.
    Br J Clin Pharmacol; 1999 May 15; 47(5):499-506. PubMed ID: 10336573
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.